PPA constraints need to be paired with real workloads, but they also need to be flexible to account for future changes.
Precigen, Inc. , a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the publication of a ...
Generative AI has achieved critical mass, with 90% industry usage and 44% of carriers reaching live production in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results